Table 1.
Parameter | Controls (n = 10) | Sepsis (n = 23) |
---|---|---|
Age mean (SD) | 49.4 (22.6) | 59.17 (17.02) |
Gender, n (%) | ||
Male | 8 (80%) | 16 (69.57%) |
Female | 2 (20%) | 7 (30.43%) |
Body mass index, kg/m2, mean (SD) | 28.13 (2.48) | 26.14 (4.61) |
Comorbidity, n (%) | 14 (60.86%) | |
Hemorrhagic cerebrovascular accident | N/A | 4 (17.39%) |
Other cerebrovascular accident (ischemia, or aneurysm) | 4 (40%) | 3 (13.04%) |
COPD | N/A | 1 (4.35%) |
Cancer | N/A | 1 (4.35%) |
Lung | N/A | 4 (17.39%) |
Liver failure | N/A | 1 (4.35%) |
Skull/spine fracture | N/A | 4 (17.39%) |
Polytrauma | 6 (60%) | 4 (17.39%) |
Mechanic ventilation | N/A | 23 (100%) |
Infection site | ||
Urinary tract | N/A | 10 (43.48%) |
Tracheal aspirate | N/A | 19 (82.61%) |
Mechanic ventilation | N/A | 23 (100%) |
Leukocytes, %/mm3, mean (SD) | N/A | 15,059.56 (10424.43) |
SOFA, mean (SD) | N/A | 5.43 (2.27) |
SAPS II, mean (SD) | N/A | 21 (9.95) |
Length of stay in hospital, days, means (SD) | N/A | 39.82 (21.21) |
Length of stay in ICU, days, mean (SD) | N/A | 18.78 (9.96) |
In-hospital mortality number (%) | N/A | 7 (30.43%) |
Gram-positive bacteria (%) | N/A | 2 (8.69%) |
Gram-negative bacteria (%) | N/A | 15 (65.21%) |
Fungus | N/A | 3 (13.04%) |
Undetermined microbial infection | N/A | 3 (13.04%) |
COPD, chronic obstructive airways disease; N/A, not applicable, SOFA, sequential organ failure assessment; SAPS, simplified acute physiology score.